1. Saran R, Robinson B, Abbott KC, Agodoa LYC, Albertus P, Ayanian J, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States Am J Kidney Dis. 2017; 69; 1-8. [
DOI:10.1053/j.ajkd.2017.01.036]
2. Nishikimi T, Nakagawa Y, Minamino N, Ikeda M, Tabei K, Fujishima A, Takayama K, Akimoto K, et al. NakaoPro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites Am. J Physiol Regul Integr Comp Physiol. 2015; 309: 639-49. [
DOI:10.1152/ajpregu.00074.2015]
3. Barquera S, Pedroza‐Tobias A, Medina C, Hernandez‐Barrera L, Bibbins‐Domingo K, Lozano R et al. Global overview of the epidemiology of atherosclerotic cardiovascular disease. Arch Med Res. 2015; 46: 328-338. [
DOI:10.1016/j.arcmed.2015.06.006]
4. Setorki M, Rafieian-Kopaei M, Merikhi A, Heidarian E, Shahinfard N, Ansari R, et al. Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits. Int J Prev Med. 2013; 4:889-95.
5. Bahmani M, Mirhoseini M, Shirzad H, Sedighi M, Shahinfard N, Rafieian-Kopaei M. A review on promising natural agents effective on hyperlipidemia. J Evid Based Complementary Altern Med. 2015; 20: 228-38. [
DOI:10.1177/2156587214568457]